SCHEMBL7850006

SCHEMBL7850006

Cc1onc(NS(=O)(=O)c2ncccc2C(=O)Nc2ccccc2)c1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
MAPT P10636 5/20 0.46
ALDH1A1 P00352 3/20 0.46
GAA P10253 1/20 0.46
EDNRB P24530 2/20 0.44
EDNRA P25101 2/20 0.44
AKR1C3 P42330 1/20 0.44
PRKCI P41743 1/20 0.44
KDM4E B2RXH2 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 3/20 0.40
LMNA P02545 1/20 0.40
GLA P06280 1/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GPR27 Q9NS67 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7857592 0.84 EDNRA (0.62) MAPTEDNRBEDNRAKDM4ERXFP1
SCHEMBL7857297 0.83 POLB (0.47) MAPTALDH1A1EDNRAKDM4ERAB9A
SCHEMBL7857544 0.80 KDM4E (0.66) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL6151272 0.76 EDNRA (0.72) EDNRBEDNRA
SCHEMBL7849845 0.73 EDNRA (0.43) EDNRBEDNRA
SCHEMBL7228577 0.72 EDNRB (0.61) ALDH1A1EDNRBEDNRANPSR1
SCHEMBL11344287 0.70 PRKCI (0.67) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL9063592 0.69 LMNA (0.48) MEN1KMT2AALDH1A1KDM4EMAPK1
SCHEMBL7715019 0.68 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1GAA
SCHEMBL7342871 0.68 EDNRB (0.64) ALDH1A1EDNRBEDNRAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1069114-A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 2001-01-17 EP claimed
EP-0870764-A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 1998-10-14 EP claimed
US-5571821-A CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-11-05 US claimed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP claimed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO claimed
WO-2001049289-A1 PHARMACEUTICAL AND VETERINARY USES OF ENDOTHELIN ANTAGONISTS TEXAS BIOTECHNOLOGY CORPORATION (US) 2001-07-12 WO disclosed
EP-1069114-A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 2001-01-17 EP disclosed
EP-0870764-A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 1998-10-14 EP disclosed
US-5571821-A CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-11-05 US disclosed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP disclosed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO disclosed